Disialoganglioside GD2-Targeted Near-Infrared Photoimmunotherapy (NIR-PIT) in Tumors of Neuroectodermal Origin

Disialoganglioside (GD2) is a subtype of glycolipids that is highly expressed in tumors of neuroectodermal origins, such as neuroblastoma and osteosarcoma. Its limited expression in normal tissues makes GD2 a potential target for precision therapy. Several anti-GD2 monoclonal antibodies are currentl...

Descripción completa

Detalles Bibliográficos
Autores principales: Inagaki, Fuyuki F., Kato, Takuya, Furusawa, Aki, Okada, Ryuhei, Wakiyama, Hiroaki, Furumoto, Hideyuki, Okuyama, Shuhei, Choyke, Peter L., Kobayashi, Hisataka
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9612122/
https://www.ncbi.nlm.nih.gov/pubmed/36297471
http://dx.doi.org/10.3390/pharmaceutics14102037

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9612122/
https://www.ncbi.nlm.nih.gov/pubmed/36297471
http://dx.doi.org/10.3390/pharmaceutics14102037

Ejemplares similares